pharmakokinetic drug interaction
TRANSCRIPT
-
8/22/2019 Pharmakokinetic Drug Interaction
1/28
PHARMACOKINETIC
DRUG INTERACTIONSubmitted Vivek Paud
Ashok Bhus
-
8/22/2019 Pharmakokinetic Drug Interaction
2/28
What is drug interaction?A drug interaction is a situation in which
substance (usually another drug) affectactivity of a drug when both are adminitogether. In other words, drug interactio
said to occur when the pharmacologicaactivity of a drug is altered by the conco
use of another drug or by the presence some other substance.
-
8/22/2019 Pharmakokinetic Drug Interaction
3/28
This action can be synergistic (when the d
effect is increased) or antagonistic (whendrugs effect is decreased) or a new effec
produced that neither produces on its owdrug whose activity is affected by such a
interaction is called as the object druganagent which precipitates such an interac
referred to as the precipitant.
-
8/22/2019 Pharmakokinetic Drug Interaction
4/28
Most of the interactions are undesirab(or harmful) whereas rare cases arefound to be desirable (beneficial): foe.g., enhancement of activity ofpenicillins when administered withprobenicid.
-
8/22/2019 Pharmakokinetic Drug Interaction
5/28
Types of drug interaction:
Drug-drug interactions
Food-drug interactions
Chemical-drug interactions
Drug-laboratory test interaction
Drug-disease interactions
-
8/22/2019 Pharmakokinetic Drug Interaction
6/28
Risk Factors:High risk patients
-Elderly, young, very sick, multiple disease
-multiple drug therapy
-Renal, liver impairment
High Risk Drugs
-Narrow therapeutic index drugs
-Recognized enzyme inhibitors or inducers
-
8/22/2019 Pharmakokinetic Drug Interaction
7/28
Mechanism Of Drug Interactions
Pharmaceutical Interactions
Pharmacokinetic Interactions
Pharmacodynamic Interactions
-
8/22/2019 Pharmakokinetic Drug Interaction
8/28
Pharmaceutical Interaction:Also called as incompatibility, it is a physicochemical interactiothat occurs when drugs are mixed in IV infusions causingprecipitation or inactivation of active principles. For e.g. ampicchlorpromazine and barbiturates interact with dextran in solutiosolutions and broken down or form chemical complexes.
Pharmacokinetic Interactions:Those interaction in which absorption, distribution, metabolism,
excretion of the drug is altered.
Pharmacodynamic Interaction:Those interaction in which the activity of the object drug at its sof action is altered by the precipitant. Such interactions may bedirect or indirect.
-
8/22/2019 Pharmakokinetic Drug Interaction
9/28
Pharmacokinetic Interactions:
These interactions are those in which theabsorption, distribution, metabolismand/or excretion of the object drug arealtered by the precipitation.
Hence also called as ADME interactions.
-
8/22/2019 Pharmakokinetic Drug Interaction
10/28
Pharmacokinetic interactions are those in
which one drug results in an alteration(increase or decrease) of the concentratanother drug in the system. The resultant ealters the plasma concentration of the ob
drug.
-
8/22/2019 Pharmakokinetic Drug Interaction
11/28
Classification:
Absorption Interactions
Distribution Interactions
Metabolism Interactions
Excretion Interactions
-
8/22/2019 Pharmakokinetic Drug Interaction
12/28
Absorption Interactions:
In this absorption of object drug is altered. Thiswill result in a reduction in the therapeutic effec
of the object drug.
This may result in:
1. Faster or slower drug absorption.2. More, or, less complete drug absorption.
-
8/22/2019 Pharmakokinetic Drug Interaction
13/28
Major Mechanisms of absorptioninteractions are: Complexation and adsorption.
Alteration in GI pH.
Alteration in gut motility.
Inhibition of GI enzyme.
Alteration of GI microflora.
Malabsorption syndrome.
-
8/22/2019 Pharmakokinetic Drug Interaction
14/28
ABSORPTIONA. Complexation/Chelation
Antacids (Mg2+, Al3+ ions)
Make complex with Tetracycline, ciprofloxacin
Reduced absorption of Tetracycline, ciprofloxac
-
8/22/2019 Pharmakokinetic Drug Interaction
15/28
ABSORPTIONB. Altered GI Transit
Anticholinergics
Block M3 receptors
Reduce motility
Delays the absorption of Acetaminophen
-
8/22/2019 Pharmakokinetic Drug Interaction
16/28
ABSORPTIONC. Altered gastric pH
H2 blockers (Ranitidine, cimetidine)
Reduce acid secretion
Increase PH
Reduce dissolution of Ketoconazole
Reduce absorption of ketoconazole
-
8/22/2019 Pharmakokinetic Drug Interaction
17/28
ABSORPTIOND. Altered GI microflora
Antibiotics
Kills the microflora of GIT
Reduce the absorption of Oral contraceptives
Unwanted pregnancy
-
8/22/2019 Pharmakokinetic Drug Interaction
18/28
Distribution Interactions
These are the interactions where the distribution patternof the object drug is altered.
The major mechanism for distribution interaction isalteration in protein-drug binding.
-
8/22/2019 Pharmakokinetic Drug Interaction
19/28
DISTRIBUTIONAlteration In Plasma protein binding
Sulfonamides, Phenytoin (Highly protein bound)
Displaces the Warfarin from plasma protein binding
Elevates free Warfarin level
Increase anticoagulant effect
Increase the risk of bleeding
-
8/22/2019 Pharmakokinetic Drug Interaction
20/28
Metabolism Interactions
Metabolism interactions are those where the metaboliof the object drug is altered.
Mechanism of metabolism interactions include:-
1. Enzyme Induction: increased rate of metabolism
2. Enzyme Inhibition: decreased rate of metabolism
-
8/22/2019 Pharmakokinetic Drug Interaction
21/28
Metabolism InteractionsA. Enzyme Induction
Phenobarbital (CYP Enzyme inducer)
Increase the metabolism of Warfarin
Reduce the plasma level of Warfarin
Decreased anticoagulant effect
-
8/22/2019 Pharmakokinetic Drug Interaction
22/28
METABOLISMB. Enzyme Inhibition
Metronidazole (CYP enzyme inhibitor)
Inhibits metabolism of Warfarin
Elevation of Plasma Warfarin levels
Raise the anticoagulant effect
Increased risk of Bleeding
-
8/22/2019 Pharmakokinetic Drug Interaction
23/28
Excretion Interactions
In this the excretion pattern of the object drug is altered.
Major mechanism of excretion interactions are-
Alteration of renal blood flow : e.g. NSAIDs (reduce renal blood flowwith lithium.
Alteration of urine pH : e.g. antacids with amphetamine.
Competition for active secretion : e.g. probenicid and penicillin. Forced diuresis.
-
8/22/2019 Pharmakokinetic Drug Interaction
24/28
EXCRETIONA. Increase in Renal blood flow
Hydralazine (Vasodilator)
Dilates the renal blood vessels
Increase the renal blood flow
Raise the clearance of Digoxin
-
8/22/2019 Pharmakokinetic Drug Interaction
25/28
EXCRETIONB. Alteration of urine pH
Antacids
Reduce acid secretion
Increase the PH of urine
Reduced tubular reabsorption of Salicylates (Aspirin)
Increased Renal clearance of Aspirin
-
8/22/2019 Pharmakokinetic Drug Interaction
26/28
EXCRETIONC. Competition for active secretion
Probenecid
Inhibits tubular secretion of Penicillins
Increase half life of Penicillins
Single dose therapy
-
8/22/2019 Pharmakokinetic Drug Interaction
27/28
References:1. Biopharmaceutics and Pharmacokinetics- A Treatise
2. Katzungs Basic & clinical Pharmacology
3. Goodman & Gilmans The Pharmacological Basis ofTherapeutics
4. www.authorstream.com
5. www.Wikipedia.com
http://www.authorstream.com/http://www.wikipedia.com/http://www.wikipedia.com/http://www.authorstream.com/ -
8/22/2019 Pharmakokinetic Drug Interaction
28/28